Browsing by Author Christodoulou, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 25  next >
TitleAuthor(s)Issue date???itemlist.???
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group StudyBriasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrationsEvangelidou, P.; Sismani, C.; Ioannides, M.; Christodoulou, C.; Koumbaris, G.; Kallikas, I.; Georgiou, I.; Velissariou, V.; Patsalis, P. C.24-Nov-2015-
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)Christodoulou, C.; Kalofonos, H. P.; Briasoulis, E.; Bafaloukos, D.; Makatsoris, T.; Koutras, A.; Skarlos, D. V.; Samantas, E.24-Nov-2015-
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyKoutras, A. K.; Kalogeras, K. T.; Dimopoulos, M. A.; Wirtz, R. M.; Dafni, U.; Briasoulis, E.; Pectasides, D.; Gogas, H.; Christodoulou, C.; Aravantinos, G.; Zografos, G.; Timotheadou, E.; Papakostas, P.; Linardou, H.; Razis, E.; Economopoulos, T.; Kalofonos, H. P.; Fountzilas, G.24-Nov-2015-
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyMalamou-Mitsi, V.; Gogas, H.; Dafni, U.; Bourli, A.; Fillipidis, T.; Sotiropoulou, M.; Vlachodimitropoulos, D.; Papadopoulos, S.; Tzaida, O.; Kafiri, G.; Kyriakou, V.; Markaki, S.; Papaspyrou, I.; Karagianni, E.; Pavlakis, K.; Toliou, T.; Scopa, C.; Papakostas, P.; Bafaloukos, D.; Christodoulou, C.; Fountzilas, G.24-Nov-2015-
FoSTeS, MMBIR and NAHR at the human proximal Xp region and the mechanisms of human Xq isochromosome formationKoumbaris, G.; Hatzisevastou-Loukidou, H.; Alexandrou, A.; Ioannides, M.; Christodoulou, C.; Fitzgerald, T.; Rajan, D.; Clayton, S.; Kitsiou-Tzeli, S.; Vermeesch, J. R.; Skordis, N.; Antoniou, P.; Kurg, A.; Georgiou, I.; Carter, N. P.; Patsalis, P. C.24-Nov-2015-
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapyFountzilas, G.; Valavanis, C.; Kotoula, V.; Eleftheraki, A. G.; Kalogeras, K. T.; Tzaida, O.; Batistatou, A.; Kronenwett, R.; Wirtz, R. M.; Bobos, M.; Timotheadou, E.; Soupos, N.; Pentheroudakis, G.; Gogas, H.; Vlachodimitropoulos, D.; Polychronidou, G.; Aravantinos, G.; Koutras, A.; Christodoulou, C.; Pectasides, D.; Arapantoni, P.24-Nov-2015-
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic studyBamias, A.; Syrigos, K.; Fountzilas, G.; Tzamakou, E.; Soulti, K.; Karavasilis, V.; Alamanos, Y.; Christodoulou, C.; Pavlidis, N.24-Nov-2015-
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancerKalofonos, H. P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K. N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G.24-Nov-2015-
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluationFountzilas, G.; Kourea, H. P.; Bobos, M.; Televantou, D.; Kotoula, V.; Papadimitriou, C.; Papazisis, K. T.; Timotheadou, E.; Efstratiou, I.; Koutras, A.; Pentheroudakis, G.; Christodoulou, C.; Aravantinos, G.; Miliaras, D.; Petraki, K.; Papandreou, C. N.; Papakostas, P.; Bafaloukos, D.; Repana, D.; Razis, E.; Pectasides, D.; Dimopoulos, A. M.24-Nov-2015-
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Kalofonos, H. P.; Dafni, U.; Papadimitriou, C.; Bafaloukos, D.; Papakostas, P.; Kalogera-Fountzila, A.; Gogas, H.; Aravantinos, G.; Moulopoulos, L. A.; Economopoulos, T.; Pectasides, D.; Maniadakis, N.; Siafaka, V.; Briasoulis, E.; Christodoulou, C.; Tsavdaridis, D.; Makrantonakis, P.; Razis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.24-Nov-2015-
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Papakostas, P.; Dafni, U.; Makatsoris, T.; Karina, M.; Kalogera-Fountzila, A.; Maniadakis, N.; Aravantinos, G.; Syrigos, K.; Bamias, A.; Christodoulou, C.; Economopoulos, T.; Kalofonos, H.; Nikolaou, A.; Angouridakis, N.; Stathopoulos, G.; Bafaloukos, D.; Pavlidis, N.; Daniilidis, J.24-Nov-2015-
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictorsPentheroudakis, G.; Fountzilas, G.; Kalofonos, H. P.; Golfinopoulos, V.; Aravantinos, G.; Bafaloukos, D.; Papakostas, P.; Pectasides, D.; Christodoulou, C.; Syrigos, K.; Economopoulos, T.; Pavlidis, N.24-Nov-2015-
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerBriasoulis, E.; Samantas, E.; Kalofonos, H.; Skarlos, D.; Makatsoris, T.; Christodoulou, C.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerAravantinos, G.; Bafaloukos, D.; Fountzilas, G.; Christodoulou, C.; Papadimitriou, C.; Pavlidis, N.; Kalofonos, H. P.; Gogas, H.; Kosmidis, P.; Dimopoulos, M. A.24-Nov-2015-
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Skarlos, D.; Dafni, U.; Gogas, H.; Briasoulis, E.; Pectasides, D.; Papadimitriou, C.; Markopoulos, C.; Polychronis, A.; Kalofonos, H. P.; Siafaka, V.; Kosmidis, P.; Timotheadou, E.; Tsavdaridis, D.; Bafaloukos, D.; Papakostas, P.; Razis, E.; Makrantonakis, P.; Aravantinos, G.; Christodoulou, C.; Dimopoulos, A. M.24-Nov-2015-
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III TrialGogas, H.; Dafni, U.; Karina, M.; Papadimitriou, C.; Batistatou, A.; Bobos, M.; Kalofonos, H. P.; Eleftheraki, A. G.; Timotheadou, E.; Bafaloukos, D.; Christodoulou, C.; Markopoulos, C.; Briasoulis, E.; Papakostas, P.; Samantas, E.; Kosmidis, P.; Stathopoulos, G. P.; Karanikiotis, C.; Pectasides, D.; Dimopoulos, M. A.; Fountzilas, G.24-Nov-2015-
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyPsyrri, A.; Kalogeras, K. T.; Kronenwett, R.; Wirtz, R. M.; Batistatou, A.; Bournakis, E.; Timotheadou, E.; Gogas, H.; Aravantinos, G.; Christodoulou, C.; Makatsoris, T.; Linardou, H.; Pectasides, D.; Pavlidis, N.; Economopoulos, T.; Fountzilas, G.24-Nov-2015-
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group studyBafaloukos, D.; Linardou, H.; Aravantinos, G.; Papadimitriou, C.; Bamias, A.; Fountzilas, G.; Kalofonos, H. P.; Kosmidis, P.; Timotheadou, E.; Makatsoris, T.; Samantas, E.; Briasoulis, E.; Christodoulou, C.; Papakostas, P.; Pectasides, D.; Dimopoulos, A. M.24-Nov-2015-
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group studyFountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Koutras, A.; Skarlos, D.; Papakostas, P.; Gogas, H.; Bafaloukos, D.; Kalogera-Fountzila, A.; Samantas, E.; Briasoulis, E.; Pectasides, D.; Maniadakis, N.; Matsiakou, F.; Aravantinos, G.; Papadimitriou, C.; Karina, M.; Christodoulou, C.; Kosmidis, P.; Kalofonos, H. P.24-Nov-2015-